Middle East Pharmaceutical Industries Company (TADAWUL: 4016)
Saudi Arabia
· Delayed Price · Currency is SAR
122.40
-0.20 (-0.16%)
Nov 20, 2024, 3:10 PM AST
Middle East Pharmaceutical Industries Company Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 21.63 | 15.11 | 23.79 | 19.04 | 15.92 |
Cash & Short-Term Investments | 21.63 | 15.11 | 23.79 | 19.04 | 15.92 |
Cash Growth | 119.44% | -36.50% | 24.98% | 19.54% | - |
Accounts Receivable | 157.71 | 155.52 | 151.57 | 164.37 | 109.86 |
Other Receivables | 3.05 | 2.16 | 3.15 | 2.68 | 2.66 |
Receivables | 160.77 | 157.68 | 154.73 | 167.05 | 112.53 |
Inventory | 99.62 | 87.17 | 100.21 | 74.45 | 82.51 |
Prepaid Expenses | 2.28 | 3.55 | 3.41 | 3.26 | 3.45 |
Other Current Assets | 10.73 | 14.14 | 9.36 | 5.57 | 10.79 |
Total Current Assets | 295.03 | 277.65 | 291.5 | 269.37 | 225.2 |
Property, Plant & Equipment | 121.47 | 119.08 | 105.86 | 103.45 | 94.72 |
Long-Term Investments | 0.57 | 1.32 | 3.61 | 9.82 | 22.72 |
Other Intangible Assets | 48.9 | 46.85 | 41.49 | 34.29 | 27.99 |
Accounts Payable | 47.31 | 28.04 | 37.95 | 32.73 | 26.2 |
Accrued Expenses | 24.53 | 18.8 | 10.91 | 7.31 | 10.06 |
Short-Term Debt | 23.79 | 50.27 | 69.13 | 66.44 | 42.05 |
Current Portion of Long-Term Debt | 6.34 | 6.34 | 6.34 | 4.75 | - |
Current Income Taxes Payable | 3.87 | 5.43 | 5.59 | 4.79 | 5.18 |
Other Current Liabilities | 1.78 | 4.36 | 1.68 | 1.37 | 1.26 |
Total Current Liabilities | 107.62 | 113.24 | 131.59 | 117.39 | 84.76 |
Long-Term Debt | - | 3.17 | 9.51 | 15.84 | 20.6 |
Common Stock | 200 | 200 | 200 | 60 | 60 |
Retained Earnings | 164.24 | 133.07 | 104.63 | 221.53 | 192.45 |
Comprehensive Income & Other | -27.09 | -26.67 | -24.36 | -14.45 | -0.02 |
Total Liabilities & Equity | 465.96 | 444.9 | 442.45 | 416.93 | 370.63 |
Total Debt | 30.13 | 59.78 | 84.97 | 87.04 | 62.65 |
Net Cash (Debt) | -8.5 | -44.67 | -61.18 | -68 | -46.73 |
Net Cash Per Share | -0.42 | -2.23 | -3.06 | -3.40 | -2.34 |
Filing Date Shares Outstanding | 20 | 20 | 20 | 20 | 20 |
Total Common Shares Outstanding | 20 | 20 | 20 | 20 | 20 |
Working Capital | 187.4 | 164.41 | 159.91 | 151.98 | 140.43 |
Book Value Per Share | 16.86 | 15.32 | 14.01 | 13.35 | 12.62 |
Tangible Book Value | 288.26 | 259.55 | 238.79 | 232.79 | 224.44 |
Tangible Book Value Per Share | 14.41 | 12.98 | 11.94 | 11.64 | 11.22 |
Land | 15.7 | 15.7 | 10.19 | 10.19 | 10.19 |
Buildings | 95.47 | 89.12 | 86.53 | 54.19 | 54.15 |
Machinery | 76.92 | 61.65 | 56.99 | 52.95 | 56.86 |
Construction In Progress | 8.92 | 25.11 | 17.33 | 46 | 26.94 |
Source: S&P Capital IQ. Standard template.
Financial Sources.